Patent decision

BL number

O/245/18

Concerning rights in

EP(UK)2308855

Hearing Officer

Mr P Thorpe

Decision date

19 April 2018

Person(s) or Company(s) involved

Novartis AG V Urquhart-Dykes & Lord LLP

Provisions discussed

Patents Act 1977 S74B

Keywords

Opinions and Reviews

Related Decisions

None

Summary

The patent proprietor requested a review of Opinion 07/17 on the grounds that the examiner had wrongly concluded that the patent was invalid for lack of inventive step and insufficiency. The patent concerns 2, 4-Diaminopyrimidine derivatives, their preparation and their use (alone or in combination with existing drugs) as kinase inhibitors, particularly zeta chain-associated protein of 70kD (also known as ZAP-70), focal adhesion kinase (also known as FAK) and/or p72syk protein tyrosine kinase (also known as syk). The Hearing Officer found that the examiner had not made any error of principle nor had he come to a conclusion on invalidity that was clearly wrong. The Opinion was not set aside.

Full decision O/245/18 81Kb